Repligen Corporation (RGEN) Set to Announce Quarterly Earnings on Thursday
Repligen Corporation (NASDAQ:RGEN) is set to issue its quarterly earnings data before the market opens on Thursday, November 9th. Analysts expect the company to announce earnings of $0.11 per share for the quarter.
Repligen Corporation (NASDAQ:RGEN) last released its quarterly earnings results on Thursday, August 3rd. The biotechnology company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.05. The firm had revenue of $32.40 million for the quarter, compared to analysts’ expectations of $31.72 million. Repligen Corporation had a return on equity of 9.90% and a net margin of 15.61%. The company’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.16 EPS. On average, analysts expect Repligen Corporation to post $0.59 EPS for the current fiscal year and $0.74 EPS for the next fiscal year.
Several research firms have recently commented on RGEN. BidaskClub upgraded shares of Repligen Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, August 9th. Zacks Investment Research upgraded shares of Repligen Corporation from a “hold” rating to a “buy” rating and set a $46.00 price objective for the company in a research note on Saturday, August 12th. TheStreet upgraded shares of Repligen Corporation from a “c+” rating to a “b-” rating in a research note on Friday, August 11th. Stephens reiterated an “overweight” rating and set a $50.00 price objective on shares of Repligen Corporation in a research note on Tuesday, September 26th. Finally, First Analysis upgraded shares of Repligen Corporation from an “equal weight” rating to an “overweight” rating and set a $47.00 price objective for the company in a research note on Monday, October 2nd. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $45.40.
WARNING: This story was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/11/02/repligen-corporation-rgen-set-to-announce-quarterly-earnings-on-thursday.html.
Repligen Corporation Company Profile
Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company’s portfolio includes protein products, chromatography products, and filtration products.
Receive News & Ratings for Repligen Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repligen Corporation and related companies with MarketBeat.com's FREE daily email newsletter.